Navigation Links
ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
Date:7/8/2008

EXTON, Pa., July 8 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) has been informed by U.S. Food and Drug Administration (FDA) that the July 23, 2008 meeting of its Advisory Committee for Pharmaceutical Science and Clinical Pharmacology is not intended to discuss specifically ViroPharma's Vancocin(R) (vancomycin hydrochloride capsules) or any other drug products. Rather, FDA has informed ViroPharma that FDA's Office of Generic Drugs (OGD) will only present for the Committee's consideration issues of general applicability to all locally acting drugs that treat gastrointestinal (GI) conditions. FDA also informed ViroPharma that any resulting recommendations by the Committee will be similarly general in nature. Additionally, ViroPharma has been advised that it will be afforded no more time to speak at the meeting than is afforded to any other member of the public, consistent with the non-product specific focus of the meeting. ViroPharma understands that the time to be provided to any one speaker will be very limited.

Based on FDA's statements to ViroPharma regarding the purpose of this meeting, made by both Committee staff and FDA's Office of Chief Counsel, ViroPharma will not discuss Vancocin at this meeting. Given ViroPharma's experience in this area, and the limited time available to speakers at the meeting, ViroPharma today submitted a letter to the Committee to aid its consideration of the general issue of bioequivalence methods for locally acting GI drugs. Among other things, ViroPharma's letter notes important issues that must be addressed in this complex area of bioequivalence method development, and attaches for the Committee's review a letter sent to FDA last year by the Infectious Diseases Society of Ameri
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Viropharma Comments On Upcoming FDA Advisory Committee Meeting
2. ViroPharma to Present at Two Upcoming Healthcare Conferences
3. ViroPharma to Present at the Seventh Annual JMP Securities Research Conference
4. ViroPharma to Present at the Cowen & Company 28th Annual Healthcare Conference
5. ViroPharma to Present at the Susquehanna Financial Group Second Annual Significant Options in Healthcare Conference
6. ViroPharma to Release 2007 Fourth Quarter and Full Year Financial Results on February 27, 2008
7. ViroPharma to Present at the BIO CEO & Investor Conference
8. ViroPharma Provides 2008 Outlook
9. ViroPharma to Present at Two Upcoming Healthcare Conferences
10. Vasogen Provides Corporate Update
11. Culligan's New Aqua-Cleer Advanced Drinking Water SystemProvides Clean, Quality Water Customized for Every Home
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The next session of Clinovo’s TechTrainings ... comprise of the increasingly popular ‘Base SAS’ and ‘CDISC ... series of technical hands-on classes for entry-level to experienced ... next step in their professional careers. , The 9-week ... Kang, Senior Statistician at Genentech and former Senior Statistician ...
(Date:7/21/2014)... of tension to a chain of carbon atoms can ... according to Rice University scientists. , Stretching the material ... carbon atoms -- by just 3 percent can begin ... find useful for mechanically activated nanoscale electronics and optics. ... and his colleagues appears in the American Chemical Society ...
(Date:7/21/2014)... 2014 ResearchMoz presents this ... USA Cancer Biomaker Market to 2018 ... ResearchMoz presents this most up-to-date research on Global ... Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, ... GLOBAL & USA ...
(Date:7/19/2014)... United States Non-Vascular Stents Market Outlook ... "United States Non-Vascular Stents Market Outlook to 2020", ... Non-Vascular Stents market. The report provides value, in ... average prices (in US dollars) within market segments ... Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially ...
Breaking Biology Technology:Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 2Clinovo TechTrainings: Next Session of SAS and CDISC Classes Start 9th September, 2014 3Carbyne morphs when stretched 2Carbyne morphs when stretched 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4
... Researchers at Duke University Medical Center, Beth Israel Deaconess ... to HIV vaccine design that uses an altered form of ... researchers showed that they could design HIV envelopes that could ... enhanced immune response in an animal model. Immature B cells ...
... new paradigm in quantum information processing has been demonstrated ... published in this week,s issue of Science Express ... integrated circuit that implements the quantum von Neumann architecture. ... can be programmed using a quantum central processing unit, ...
... Md., Sept. 1, 2011 Neuralstem, Inc. (NYSE Amex: ... Richard Garr will present at the 2011 Stifel Nicolaus ... a.m. EDT. Garr will discuss the Company,s opportunities and ... and will be providing an update on the ongoing ...
Cached Biology Technology:New HIV vaccine approach targets desirable immune cells 2New HIV vaccine approach targets desirable immune cells 3Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference 2Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference 3
(Date:7/21/2014)... 21, 2014 (Toronto) As part of a multinational, ... Mental Health (CAMH) have helped identify over 100 locations ... developing schizophrenia, in what is the largest genomic study ... published online in Nature , point to biological ... lead to new approaches to treating the disorder, which ...
(Date:7/21/2014)... seals, every movement, researchers have shown for the first ... wind farms and pipelines. Those man-made structures probably serve ... a study published in the Cell Press journal ... was shocked when I first saw the stunning grid ... offshore wind farm in the United Kingdom, says Deborah ...
(Date:7/21/2014)... A University of California, San Diego School of Medicine-led ... not recognize the potentially serious health consequences of childhood ... in helping their child reach a healthy weight. , ... of the Academy of Nutrition and Dietetics . , ... and physical activity behaviors," said lead author Kyung Rhee, ...
Breaking Biology News(10 mins):International team sheds new light on biology underlying schizophrenia 2International team sheds new light on biology underlying schizophrenia 3Seals forage at offshore wind farms 2Parents rank their obese children as 'very healthy' 2
... Va. (Sept. 27, 2010) -- Renowned international experts ... inhalable vaccines for human papillomavirus and tuberculosis to ... 2010 FIP Pharmaceutical Sciences World Congress (PSWC) in ... (AAPS) Annual Meeting and Exposition in New Orleans, ...
... (September 28, 2010) New findings from Van ... that help plants survive drought and other stresses in harsh ... a follow-up to findings published in Nature last ... by Science magazine. "I think that the ...
... Kavli Science Forum: 2010 in Oslo, Dr. John P. Holdren -- ... why climate change is a priority to the Obama administration, and ... to, what he termed the effects of "global climate disruption." ... any of us - as individual nations," he stated. "We need ...
Cached Biology News:New VARI findings next step to growing drought-resistant plants 2John P. Holdren addresses climate change, stressing need for international cooperation 2
Form: Ready to use Applications: ELISA...
Form: Ready to use Applications: ELISA...
ANTI S. GROUP AG:H...
Recorder REC-111 single-channel, 1. Category: Chromatography Systems & Accessories, Systems....
Biology Products: